Search Results (142)
Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA. | Academic Article |
Why?
|
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial. | Academic Article |
Why?
|
A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis. | Academic Article |
Why?
|
Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis. | Academic Article |
Why?
|
Glucocorticoids in systemic sclerosis: patients' beliefs and treatment adherence. | Academic Article |
Why?
|
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. | Academic Article |
Why?
|
Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis. | Academic Article |
Why?
|
Watermelon stomach following and preceding systemic sclerosis. | Academic Article |
Why?
|
Paraparesis in a patient with systemic sclerosis. | Academic Article |
Why?
|
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. | Academic Article |
Why?
|
Quality indicator set for systemic sclerosis. | Academic Article |
Why?
|
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. | Academic Article |
Why?
|
Scleroderma, Systemic | Concept |
Why?
|
Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients. | Academic Article |
Why?
|
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. | Academic Article |
Why?
|